Crystallization In Syrup after supplier change: water system and sanitation checks


Published on 29/12/2025

Identifying and Addressing Crystallization in Syrups Following Supplier Changes

In the pharmaceutical manufacturing landscape, the integrity of liquid oral dosage forms, such as syrups, is paramount. A recent challenge arises when crystallization in syrup products occurs after a supplier change. Such occurrences can lead to Out-of-Specification (OOS) results, deviations, or quality complaints, thereby necessitating comprehensive investigations that ensure compliance with Good Manufacturing Practices (GMP). This article will guide you through a structured approach to investigate and resolve issues related to syrup crystallization while maintaining inspection readiness.

By following the investigation framework outlined here, readers will learn how to identify key signals, analyze potential causes, and implement corrective and preventive actions (CAPA) to mitigate risks associated with formulation changes. Additionally, this investigation will highlight how effective control strategies can enhance long-term product stability and regulatory compliance.

Symptoms/Signals on the Floor or in the Lab

The investigation into crystallization in syrup begins with the initial signals observed either during the manufacturing process or in the

quality control laboratory. Symptoms may include:

  • Visual precipitation or turbidity in the syrup batch.
  • Altered rheological properties measured during flow testing.
  • Out-of-Specification (OOS) results in assays for active ingredients.
  • Increased viscosity or difficulty in packaging the syrup.
  • Customer complaints regarding changes in product consistency or taste.

It is essential to document these symptoms promptly to initiate a thorough investigation. Observational data will form the basis for identifying trends, as deviations may vary based on process conditions and supplier impacts. The investigation must also consider any variations introduced during the supplier change, including raw materials and water used in formulation.

Likely Causes

Upon identifying symptoms, the next step is to categorize and hypothesize potential causes of crystallization under the following areas:

Category Potential Causes
Materials Quality variations in new sugar sources, additives, or active pharmaceutical ingredients (APIs).
Method Changes in preparation procedures, such as mixing times or temperatures.
Machine Inadequate calibration of mixing or heating equipment affecting consistency.
Man Insufficient training related to new supplier materials handling or procedures.
Measurement Inaccurate monitoring of critical parameters (e.g., pH, temperature, concentration).
Environment Variability in humidity or temperature in production and storage areas.
Pharma Tip:  Assay Oos at accelerated stability: packaging and transport risk assessment

Leveraging this table as a reference, teams can initiate discussions around evidence gathering to support or rule out these hypotheses.

Immediate Containment Actions

Within the first 60 minutes of detecting crystallization in syrup, immediate containment actions should be employed to ensure product safety and quality. These actions may include:

  • Halting the current production batch to prevent further issues.
  • Isolating affected product batches to prevent mixing with non-affected products.
  • Assessing and documenting the inventory of raw materials from the new supplier.
  • Controlling environmental factors by checking and stabilizing temperature and humidity in production areas.
  • Communicating with the quality control team to prepare for an in-depth investigation.

Documenting these immediate actions is vital for compliance and record-keeping purposes, establishing a clear timeline of responses to the identified issue.

Investigation Workflow

A cohesive investigation workflow should be established to guide the troubleshooting process regarding crystallization. Important data to collect include:

  • Batch records for affected syrup products, including components used.
  • Environmental monitoring logs to confirm controlled conditions during production.
  • Quality control test results for both in-process and finished products.
  • Supplier change documentation that details material specifications and certifications.
  • Training records for operators involved in the production process.

Interpreting the collected data should involve:

  • Reviewing correlations between material changes and symptoms observed.
  • Comparing OOS results against historical performance data to identify anomalies.
  • Conducting interviews with personnel involved to gather insights regarding operational changes.

Root Cause Tools

To accurately pinpoint the root cause of crystallization, several investigation tools can be employed:

  • 5-Why Analysis: This technique requires iteratively asking ‘why’ to peel back layers of symptoms until the underlying issue is identified. Use this when initial causes appear broad.
  • Fishbone Diagram: Also known as Ishikawa, this tool categorizes potential causes allowing teams to visualize multiple pathways that could lead to crystallization. It is useful for brainstorming sessions with cross-functional teams.
  • Fault Tree Analysis: This deductive reasoning tool helps in understanding the pathways leading to failures. It’s most effective in complex scenarios where many interacting components exist.

Employing these tools collectively facilitates a deeper understanding of root causes, hence enhancing the accuracy of the findings.

CAPA Strategy

Corrective and Preventive Action (CAPA) must hinge on the identified root causes from the investigation. This includes:

  • Correction: Immediate steps taken to remedy the specific batch issues, such as reworking the syrup if feasible or moving it to quarantine.
  • Corrective Action: Long-term measures addressing factors contributing to crystallization, such as altering supplier onboarding processes, enhancing quality checks for incoming materials, or re-evaluating production procedures.
  • Preventive Action: Implementing ongoing monitoring and snapshot assessments of supplier materials and potential crystallization risks, including training operators to recognize the importance of GMP adherence.
Pharma Tip:  Ph Drift during filling line setup: packaging and transport risk assessment

The foundation of a robust CAPA strategy is documentation, which serves as evidence during regulatory inspections and audits.

Control Strategy & Monitoring

A comprehensive control strategy helps ensure that crystallization risks are mitigated over time. Key elements of a successful control strategy include:

  • Statistical Process Control (SPC): Employing real-time data analysis for critical process parameters to track manufacturing consistency.
  • Frequent Sampling: Establishing a frequency for in-process and finished product sampling to detect early signs of crystallization before it escalates.
  • Alarms and Alerts: Utilizing automated systems that monitor variables (temperature, humidity, etc.) and trigger alarms when thresholds exceed set limits.
  • Verification Processes: Regularly conducting product integrity checks post-manufacture to ensure no crystallization has developed in the finished product stored within the warehouse.

By strengthening the control strategy, organizations can enhance their response readiness and ensure broader product stability and quality assurance.

Related Reads

Validation / Re-qualification / Change Control Impact

When crystallization issues arise, a careful review of validation, re-qualification, and change control procedures is essential. Considerations include:

  • Assessing if the change in supplier materials necessitates a re-validation of the production process due to different characteristics that may affect product behavior.
  • Determining whether equipment must be re-qualified if many variables impact the mixing, heating, or storage processes.
  • Documenting any changes to the standard operating procedures (SOPs) related to the formulation process and thoroughly updating batch records to reflect these procedural changes.

Implementing an effective change control process enables a company to address and validate risks associated with new suppliers or raw materials, ultimately promoting higher standards of compliance as per the guidelines provided by regulatory bodies like the FDA or EMA.

Inspection Readiness: What Evidence to Show

To maintain inspection readiness and demonstrate due diligence during regulatory audits, pharmaceutical organizations should compile and maintain the following documentation:

  • Records of all investigations related to crystallization incidents, including timelines, personnel involved, and outcomes of the CAPA efforts.
  • Logs of environmental controls performed and observations made throughout the process.
  • Deviation reports compiled as a result of investigations pointing to the crystallization issue.
  • Batch production records, including raw material certifications and handling process documentation promoting transparency.
  • Evidence of training for staff in relation to new procedures stemming from supplier changes.
Pharma Tip:  Hold Time Bioburden Rise during method transfer: water system and sanitation checks

Collectively maintaining such records not only prepares companies for successful inspections but also reinforces their commitment to GMP compliance and product quality across the board.

FAQs

What should I do if crystallization is observed in a syrup batch?

Immediately halt production, isolate affected batches, and initiate an investigation into potential causes as outlined in this article.

How can I prevent crystallization from recurring?

Implement a robust CAPA strategy and an effective control strategy that includes ongoing monitoring and periodic training for employees on new supplier materials.

What materials should be scrutinized during an investigation?

Focus on raw materials from the new supplier, including their quality specifications and certificate of analysis (CoA).

What role does environmental control play in syrup stability?

Environmental factors such as temperature and humidity can significantly influence syrup formulation stability, necessitating diligence in monitoring these parameters.

How often should training be conducted for staff regarding supplier changes?

Training should occur whenever there are changes in suppliers or new formulations, with regular refreshers to maintain standards and awareness.

What documentation is required during a deviation investigation?

Maintain investigation records, batch production records, OOS results, environmental monitoring logs, and relevant CAPA documentation.

Do I need re-validation after a supplier change?

Yes, re-validation may be necessary if the new materials or processes significantly differ from those previously validated.

How can I streamline my change control process?

Develop clear procedures for assessing changes and ensure consistent documentation and training for staff regarding new processes.

What are the regulatory implications of failing to investigate crystallization?

Failure to investigate adequately can result in non-compliance findings during inspections, potentially leading to product recalls and regulatory penalties.

How do I communicate findings from an investigation to management?

Prepare a detailed report summarizing your findings, actions taken, and future recommendations, presenting key points clearly and concisely during management meetings.

What is the significance of SPC in monitoring syrup production?

SPC involves using statistical methods to monitor and control the production process, helping detect variations that may lead to issues like crystallization early on.